A detailed history of Pacific Sage Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pacific Sage Partners, LLC holds 1,936 shares of MRK stock, worth $223,124. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,936
Previous 2,004 3.39%
Holding current value
$223,124
Previous $218 Million 16.93%
% of portfolio
0.07%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$113.24 - $131.95 $7,700 - $8,972
-68 Reduced 3.39%
1,936 $255 Million
Q4 2023

Feb 05, 2024

BUY
$100.18 - $109.02 $200,760 - $218,476
2,004 New
2,004 $218 Million
Q2 2023

Jul 20, 2023

BUY
$108.61 - $118.38 $108 - $118
1 Added 0.05%
1,962 $226 Million
Q1 2023

May 02, 2023

SELL
$102.94 - $114.86 $27,690 - $30,897
-269 Reduced 12.06%
1,961 $209 Million
Q4 2022

Jan 31, 2023

BUY
$87.44 - $112.11 $194,991 - $250,005
2,230 New
2,230 $247 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $292B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Pacific Sage Partners, LLC Portfolio

Follow Pacific Sage Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Sage Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Sage Partners, LLC with notifications on news.